MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
2022: The 14 fastest-growing healthcare companies
Repligen Corporation (Nasdaq:RGEN)
Organization & Developments: Repilgen
Parents
Repligen Corporation (Nasdaq:RGEN)
Children
*Repligen Corp (RGEN) - DEVELOPS CONSUMABLE BIOPROCESSING PRODUCTS FOR LIFE SCIENCES COMPANIES
*Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs.
2014: Repligen Announces Asset Purchase Agreement With BioMarin for HDACi Portfolio (2014)
2014: Repligen Corporation Continuing Overhaul Flips Rare Disease Drugs To BioMarin Pharmaceutical Inc. (BMRN) (2014)
2018: Highly Rated 'Surgeon' For Biologic-Drug Makers Soars 85% In 2018
2023: Repligen: Hard To Justify Stock's Current Valuation_ seekingalpha.com
2024: Repligen Corporation's Earnings Preview: Expensive With Mixed Growth Prospects
2025: Repligen: Long-Term Growth Gem Suffers Some Setbacks
Jumps
*Key People: Repligen
Finance & Acquisitions: Repilgen